UK trade body to lead delegations to India focusing biotech industry
The UK Trade and Investment (UKTI), a government investment services organization, will focus on promoting trade and investment relation between the biopharmaceutical industry in the UK and India by arranging business meetings in next month or two.
The organization's Bangalore, India, which unit helps businesses locate in the UK and grow internationally, is planning to lead a 10-member business delegation of biotech firms from Britain to India, from March 15, 2010. The delegation, consisting of small and medium-sized biopharma companies would visit biotherapeutic firms in Mumbai, Hyderabad and Bangalore on consecutive days in order to understand the strengths of the Indian industry, said an official from the UKTI.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Biotechnology
| Headless Content Management with Blaze